Wall Street analysts expect Steris PLC (NYSE:STE) to report $673.53 million in sales for the current quarter, according to Zacks Investment Research. Three analysts have issued estimates for Steris’ earnings. The lowest sales estimate is $669.10 million and the highest is $676.10 million. Steris posted sales of $638.76 million in the same quarter last year, which would indicate a positive year over year growth rate of 5.4%. The firm is expected to report its next earnings results on Wednesday, August 14th.
According to Zacks, analysts expect that Steris will report full year sales of $2.94 billion for the current year. For the next year, analysts forecast that the firm will report sales of $3.10 billion, with estimates ranging from $3.09 billion to $3.11 billion. Zacks’ sales calculations are an average based on a survey of sell-side research firms that cover Steris.
Steris (NYSE:STE) last announced its earnings results on Monday, May 13th. The medical equipment provider reported $1.53 EPS for the quarter, topping the consensus estimate of $1.44 by $0.09. The business had revenue of $768.00 million during the quarter, compared to the consensus estimate of $738.87 million. Steris had a net margin of 10.93% and a return on equity of 13.34%. Steris’s revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.24 EPS.
Shares of STE stock opened at $140.90 on Tuesday. The stock has a market cap of $11.67 billion, a P/E ratio of 28.81 and a beta of 0.95. The company has a quick ratio of 1.82, a current ratio of 2.27 and a debt-to-equity ratio of 0.37. Steris has a 52 week low of $99.14 and a 52 week high of $141.26.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Wednesday, June 12th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.97%. The ex-dividend date of this dividend is Tuesday, June 11th. Steris’s dividend payout ratio is currently 27.81%.
In other news, Director Richard Martin Steeves sold 72,867 shares of the business’s stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $136.78, for a total value of $9,966,748.26. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Walter M. Rosebrough, Jr. sold 119,000 shares of the business’s stock in a transaction that occurred on Friday, May 31st. The shares were sold at an average price of $132.56, for a total transaction of $15,774,640.00. The disclosure for this sale can be found here. Insiders sold a total of 259,785 shares of company stock valued at $34,402,980 in the last three months. Insiders own 2.36% of the company’s stock.
Large investors have recently modified their holdings of the company. Oregon Public Employees Retirement Fund raised its position in shares of Steris by 10,585.0% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 3,572,743 shares of the medical equipment provider’s stock valued at $33,000 after buying an additional 3,539,306 shares in the last quarter. Advisory Services Network LLC increased its position in Steris by 26.0% during the 4th quarter. Advisory Services Network LLC now owns 427 shares of the medical equipment provider’s stock worth $45,000 after purchasing an additional 88 shares in the last quarter. Executive Wealth Management LLC acquired a new position in Steris during the 4th quarter worth approximately $47,000. Pinebridge Investments L.P. acquired a new position in Steris during the 1st quarter worth approximately $50,000. Finally, Enlightenment Research LLC acquired a new position in Steris during the 4th quarter worth approximately $53,000. Institutional investors own 83.37% of the company’s stock.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Read More: Diluted Earnings Per Share
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.